These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17163876)

  • 21. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of a policy to permit the return of donors repeat-reactive to the Abbott PRISM antibody to hepatitis B core antigen assay.
    O'Brien SF; Yi QL; Fan W; Fearon MA; Scalia V; Goldman M
    Transfusion; 2009 Feb; 49(2):271-7. PubMed ID: 19389210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occult hepatitis B virus infection.
    Allain JP
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-HBc testing in an effort to reduce the incidence of posttransfusion non-A, non-B hepatitis.
    Kline WE
    Beitr Infusionther Klin Ernahr; 1987; 18():6-12. PubMed ID: 3125834
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevalence of antibody to Hepatitis B core antigen and Hepatitis B virus DNA in HBsAg negative healthy blood donors.
    Karimi G; Zadsar M; Vafaei N; Sharifi Z; FalahTafti M
    Virol J; 2016 Mar; 13():36. PubMed ID: 26944046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-transfusion hepatitis B transmitted by HBsAg negative blood containing anti-HBc.
    Dike AE
    Med Lab Sci; 1981 Oct; 38(4):415-7. PubMed ID: 7329229
    [No Abstract]   [Full Text] [Related]  

  • 27. [Studies on hepatitis B virus infection in blood donors with positive anti-HBc and negative HBsAg].
    Ren F; Li H; Zhao H
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jan; 32(1):7-9. PubMed ID: 10322742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleic acid amplification technology for screening of HBV DNA among anti-HBc-positive units of blood and blood donors.
    Panhotra BR; Joshi CS; ul Hassan Z; Bahrani A
    Transfus Med; 2006 Feb; 16(1):73-4. PubMed ID: 16480443
    [No Abstract]   [Full Text] [Related]  

  • 29. Should antibody to hepatitis B core antigen be tested in routine screening of donor corneas for transplant?
    Mattern RM; Cavanagh HD
    Cornea; 1997 Mar; 16(2):138-45. PubMed ID: 9071525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An experience of the use of Anti-HBc and Anti-HBs for blood donor screening tests at a tertiary hospital blood center in Korea].
    Lim YA; Yoon S
    Korean J Lab Med; 2009 Feb; 29(1):59-65. PubMed ID: 19262080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
    O'Brien SF; Fearon MA; Yi QL; Fan W; Scalia V; Muntz IR; Vamvakas EC
    Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases.
    Laperche S; Maniez M; Barlet V; El Ghouzzi MH; Le Vacon F; Levayer T; Lunel F; Morel P; Mouillot L; Piquet Y; Pillonel J;
    Transfusion; 2008 Nov; 48(11):2308-14. PubMed ID: 18673347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-HBc testing is reliable for blood donor screening.
    Smilovici W; Ducos J; Mariniere A
    Lancet; 1984 May; 1(8384):1024. PubMed ID: 6143954
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors.
    Seo DH; Whang DH; Song EY; Kim HS; Park Q
    Transfusion; 2011 Aug; 51(8):1840-6. PubMed ID: 21332731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies for the prevention of post-transfusion hepatitis.
    Mintz PD
    Ann Clin Lab Sci; 1984; 14(3):198-207. PubMed ID: 6428295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of detecting anti-HBc among Egyptian male blood donors negative for HBsAg.
    Antar W; El-Shokry MH; Abd El Hamid WA; Helmy MF
    Transfus Med; 2010 Dec; 20(6):409-13. PubMed ID: 20573069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity and specificity of Anti-HBc screening assays--which assay is best for blood donor screening?
    Hourfar MK; Walch LA; Geusendam G; Dengler T; Janetzko K; Gubbe K; Frank K; Karl A; Löhr M; Sireis W; Seifried E; Schmidt M
    Int J Lab Hematol; 2009 Dec; 31(6):649-56. PubMed ID: 18673399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen.
    Hoofnagle JH; Seeff LB; Bales ZB; Zimmerman HJ
    N Engl J Med; 1978 Jun; 298(25):1379-83. PubMed ID: 652005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of "anti-HBc alone" among Syrian blood donors.
    Muselmani W; Habbal W; Monem F
    J Infect Dev Ctries; 2014 Aug; 8(8):1013-5. PubMed ID: 25116667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.